Table 2. Summary of the meta-analysis of m6A regulators and prognosis in cancer patients.

Regulators	Outcome	Studies	HR	95% Cl	P-value	Heterogeneity		Effects model
						I2	P-value
METTL3	OS	21	1.75	1.32–2.31	0	78.10%	0	Random
	DFS	7	2.02	1.54–2.64	0	52%	0.052	Random
METTL14	OS	4	0.55	0.43–0.69	0	0.00%	0.392	Random
KIAA1429	OS	2	2.35	1.40–3.93	0.001	37.20%	0.207	Random
METTL16	OS	2	1.75	0.84–3.65	0.137	82.20%	0.018	Random
ALKBH5	OS	8	1.09	0.75–1.57	0.657	62.50%	0.009	Random
FTO	OS	10	1.01	0.72–1.41	0.966	74.70%	0	Random
YTHDF1	OS	6	1.21	0.67–2.18	0.532	72.10%	0.003	Random
YTHDF2	OS	3	0.9	0.52–1.57	0.715	80.10%	0.007	Random

Abbreviations: CI: confidence interval; HR: hazard ratio; OS: overall survival; DFS: disease-free survival.